Literature DB >> 1433223

Isobenzofurans as conformationally constrained miconazole analogues with improved antifungal potency.

R G Lovey1, A J Elliott, J J Kaminski, D Loebenberg, R M Parmegiani, D F Rane, V M Girijavallabhan, R E Pike, H Guzik, B Antonacci.   

Abstract

A series of halogen-substituted isobenzofuran analogues was synthesized, which represented conformationally constrained analogues of miconazole (1). In vitro and in vivo topical antifungal activity against both dermatophytes and Candida species varied widely, but 13c proved to be significantly superior to both 1 and clotrimazole against a vaginal Candida infection in hamsters, while 13b was significantly more active than 1 against a a topical Trichophyton infection in guinea pigs. None of the compounds were orally active. When the most direct analogue of 1 proved to be among the least active, a molecular modeling study was done using 1, the two active analogues 13b and 13c, and the inactive analogue 13a. All four compounds possessed skeletally similar conformations either at or energetically readily accessible from the global minimum energy conformations. This common conformation of the inactive analogue 13a, however, occupies unique molecular volume space associated with two chlorine atoms, which must also present unique electrostatic properties at the receptor. The conformation-activity relationships discussed may contribute toward deduction of additional structural requirements for pharmacophore optimization and more efficacious antifungal drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433223     DOI: 10.1021/jm00100a030

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Design, synthesis, and biological activities of novel azole-bonded β-hydroxypropyl oxime O-ethers.

Authors:  Somayeh Behrouz; Mohammad Navid Soltani Rad; Saeid Rostami; Marzieh Behrouz; Elham Zarehnezhad; Ali Zarehnezhad
Journal:  Mol Divers       Date:  2014-08-01       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.